Renaissance Capital logo

HTGM News

Genetic tests in a jam: AutoGenomics withdraws third IPO attempt

AutoGenomics, which sells a molecular diagnostics system for genetic testing in clinical laboratories, withdrew its plans for an initial public offering on Monday. It had first filed to go public in 2008 but withdrew its plans in 2011. It then set terms in...read more

US IPO Weekly Recap: With 8 IPOs it's Bo-Time for Bojangles and no time for biotechs

14 companies were scheduled to go public this week, including 10 health care deals. Only 8 IPOs got through, as 3 biotechs have been pushed back to next week, two companies postponed and one withdrew. however; IPO investors had plenty of options while the NASDAQ...read more

HTG Molecular Diagnostics prices IPO at $14 midpoint and begins trading Wednesday

HTG Molecular Diagnostics, which markets a diagnostic platform for complex molecular profiling, raised $50 million by offering 3.6 million shares at $14, the midpoint of its $13 to $15 range. It priced and began trading on Wednesday. The week's other...read more

Week ahead: 14 IPOs planned for the week of May 4

This could be the busiest 5-day stretch in the IPO market since the week of July 28, 2014, as 14 companies look to raise nearly $2 billion. However, ...read more